Bruce Strober

,

MD, PhD

Dr. Strober earned his medical and doctorate degrees from Columbia University in New York, later completing his dermatology residency at the New York University School of Medicine. As a board-certified dermatologist and Fellow of the American Academy of Dermatology, Dr. Strober has cultivated a distinguished career in both academic and clinical settings, enhancing dermatological care through a focus on challenging inflammatory conditions.

Specializing in the treatment of complex inflammatory skin diseases, such as psoriasis, atopic dermatitis, and hidradenitis suppurativa, Dr. Strober is highly regarded for his strategic insights and clinical expertise that drive therapeutic success in these areas.

As a Founding Partner of MTC³ , Dr. Strober provides clients with in-depth analysis and customized guidance, leveraging his years of experience to address intricate dermatological challenges with clarity and impact.

In addition to his role at MTC³, Dr. Strober serves as Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis and is the Scientific Co-Director of the CorEvitas Psoriasis Registry. His involvement as Vice President and President-elect of the Board of the International Psoriasis Council further underscores his leadership in dermatological innovation and treatment advancements.

Throughout his career, Dr. Strober has contributed to high-impact publications and research initiatives, solidifying his reputation as an authority in dermatology and influencing advancements in the management and understanding of psoriasis and other inflammatory conditions.